First at-home treatment for molluscum contagiosum wins FDA approval

FDA approved berdazimer topical gel (Zelsumvi) for the treatment of molluscum contagiosum in adults and pediatric patients ≥1 year of age. According to the manufacturer, Zelsumvi is the first topical medication that can be applied outside of a clinical setting by patients, parents, or caregivers.